Outcomes due to CSVT
No mortality secondary to CSVT was observed in our study. Neuroimaging (CT and MR venography) was used for follow-up. After 3 months, the majority of patients had complete radiological resolution following anticoagulation (LMWH). Some patients continued to receive LMWH, if there were more scheduled Asp doses to receive. No recurrent CSVT was observed. Only one patient whose anticoagulation was not started immediately upon diagnosis because of a large concomitant bleed, ended up with a minor neurologic deficit.